Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2018-01-29

Clinical Trial Update: The Efficacy of Fluticasone Furoate/Vilanterol Versus (vs) Fluticasone Furoate on Asthma [Phase 4]

View source ↗

Summary

Phase 4 trial comparing fluticasone furoate/vilanterol to fluticasone furoate in asthma has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fluticasone Furoate (fluticasone furoate)
  • Fluticasone Furoate/Vilanterol (fluticasone furoate/vilanterol)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Asthma | Phase 4 | Status: WITHDRAWN